期刊文献+

苍附导痰汤在治疗多囊卵巢综合征中的可行性研究 被引量:11

Treating polycystic ovary syndrome with the Cangfu Daotan decoction
下载PDF
导出
摘要 目的:探讨苍附导痰汤治疗多囊卵巢综合征的临床疗效和安全性。方法:选取在我院妇科门诊就诊的64例多囊卵巢综合征患者,将其随机均分为对照组和观察组。对照组采用口服二甲双胍肠溶片治疗;观察组在对照组的基础上给予苍附导痰汤治疗。比较两组患者治疗后性激素水平及排卵率差异。结果:两组患者治疗后性激素水平均有显著改善,观察组治疗后雌二醇含量为(36.42±6.81)pmol/L,显著高于对照组(P<0.05),其他激素水平组间比较无统计学差异(P>0.05)。观察组排卵率为90.6%,显著高于对照组的68.8%(P<0.05)。结论:苍附导痰汤治疗多囊卵巢综合征疗效确切,能有效调节患者的激素水平,显著提高排卵率,值得临床推广使用。 Objective: To investigate clinical efficacy and safety of the Cangfu Daotan decoction on polycystic ovary syndrome. Methods: 64 patients of polycystic ovary syndrome were randomly divided into the control group and the observation group. The control group was treated with the enteric-coated tablets; observation group was given the Cangfu Daotan decoction. Sex hormone levels and ovulation rate between two groups were recorded. Results: After treatment levels of sex hormones were significantly improved, estradiol in the observation group(36.42 ± 6.81) pmol / L, significantly higher(P〈0.05), among other groups no hormone levels statistically significant difference(P〉0.05). Ovulation in the observation group was 90.6%, significantly higher than the 68.8% in the control group(P〈0.05). Conclusion: The Cangfu Daotan decoction for polycystic ovary syndrome can effectively regulate hormone levels in patients, significantly increase ovulation rate.
作者 曾小吉
机构地区 揭西县人民医院
出处 《中医临床研究》 2015年第19期101-102,共2页 Clinical Journal Of Chinese Medicine
关键词 苍附导痰汤 多囊卵巢综合征 二甲双胍肠溶片 排卵率 The Cangfu Daotan decoction Polycystic ovary syndrome Metformin enteric-coated tablets Ovulation rate
  • 相关文献

参考文献4

二级参考文献18

  • 1王玮,蔡建辉,马毓梅,徐素欣,郝桂敏,李晓冬.GLUT4在多囊卵巢综合征大鼠子宫内膜中的表达及意义[J].中国病理生理杂志,2007,23(3):587-590. 被引量:9
  • 2柳顺玉,阮祥燕.多囊卵巢综合征的研究进展[J].中国妇幼保健,2007,22(14):1999-2001. 被引量:4
  • 3Diamanti KE, Kouli CR, Bergiele AT, et al. A survey of the poly- cystic ovary syndrome in the Greek island of 1. esbos:hormonal and metabolic profile [ J ]. J Ctin Endocrinol Metab, 1999,81 : 4006 - 4011.
  • 4Amer P. Insulin resistance in type 2 diabetes - role of the adipo- kines[ J]. Curt" Mol Med,2005,5 (3) :333.
  • 5Behre C J, Brohail G, Hulthe J, et al. Serum adiponeefin in a popu2 lation sample of 642year2old women in re ] ation to glucose tolerance, family history of diabetes, autoimmunity, insulin semid- vity, CZpep2 tide, and inflammation [ J ]. Metabolism, 2006,55 (2) :188.
  • 6Knobler H, Bendedy M, Boyko V, et al. Adiponectin and thevelopment of diabetes in patients with coronary artery disease and impaired fasting glucose [ J]. Eur J Endocrinol, 2006,154 ( 1 ) : 87.
  • 7Yamamoto Y, Hirose H, Saito I, et al. Adiponectin, an Adipocyte derived protein,preaicts future insulin resistahoe:tw0 years follow up study in Japanese population [J] J Clin Endoerinol Metab, 2004,89( 1 ) :87.
  • 8Ardawi M, Rouzi A. Plasma adiponeetin and insul in resistance in women with polycystic ovary syndrome [ J ]. Fertil Steri1,2005,83 (6) :1708.
  • 9Vrbikova J, Dvorakova K, Hill M, et al. Determinants of circulat- ing adiponectin in women with polycystic ovmy syndrome [J] Gvnecol Obstet Invest ,2005,60 ( 3 ) : 155.
  • 10Gale SM, Castracane VD, Mantzoros CS. Energy homeostasis o- besity and eating disorde is recent advances in endocrinolgy [J]. Nutr, 2004,134(2) :295 -298.

共引文献77

同被引文献135

引证文献11

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部